23.01.2017 • NewschemicalsDede WillamsDownstream

SABIC to Buy Shell Stake in SADAF

(c) Shell
(c) Shell

Saudi petrochemicals giant SABIC and oil-chemicals major Shell have has signed an agreement calling for SABIC to acquire Shell’s 50% share in the joint venture in Shell Arabia (SADAF) for $820 million, the two groups announced on Jan. 22. The Saudi group is exercising an option of the original agreement allowing it to renew or end the partnership by the end of 2020. SABIC said it hopes to complete the transaction is before the end of this year.

The transfer price is based on the net value of the jv’s assets.  The company established in 1980 operates six petrochemical plants at Al Jubail, on the Gulf coast of Saudi Arabia, with total annual output of over 4 million t/y of chemicals, including ethylene, crude industrial ethanol and styrene.

Simultaneously, the partners have signed a Memorandum of Understanding (MoU) to boost their cooperation on other unspecified international and local investments. “We will continue to explore potential future opportunities with SABIC,” Graham van’t Hoff, executive vice president of chemicals at Shell, told news agencies.

Shell said the acquisition will enable SABIC to further optimize operations at SADAF and invest in additional funds in the facilities, integrating them with its other affiliates. By the same token,  Shell will be able to focus its downstream activities and make selective investments to support the growth of its global chemicals business. The group based in the Netherlands and the UK is already involved in other downstream activities in Saudi Arabia, among other things a crude oil refinery with Saudi Aramco in Jubail.

In 2014, SABIC and Shell canceled plans to expand SADAF as feasibility studies did not produce encouraging results. The expansion would have added production of polyols, propylene oxide and styrene monomer.

Last week, sources told the news agency Reuters reported that SABIC was in talks with banks to raise as much as $2 billion in loans. They said the loans could be transferred to Saudi Kayan Petrochemicals Co., in which SABIC holds a 35%. It is as yet unclear whether the loans are connected to the agreement with Shell. The Saudi group faces a challenging year in 2017 and needs to focus on improving efficiency, CEO Yousef al Benyan said in autumn of last year.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.